Financials Pilulka Lékárny

Equities

PINK

CZ0009009874

Drug Retailers

End-of-day quote Prague S.E. 23:00:00 12/05/2024 BST 5-day change 1st Jan Change
180 CZK 0.00% Intraday chart for Pilulka Lékárny +4.65% -26.83%

Valuation

Fiscal Period: December 2021 2022
Capitalization 1 - -
Enterprise Value (EV) 1 - -
P/E ratio - -25.2 x
Yield - -
Capitalization / Revenue - -
EV / Revenue - -
EV / EBITDA - -
EV / FCF - -
FCF Yield - -
Price to Book - 11.7 x
Nbr of stocks (in thousands) - -
Reference price 2 1,685 650.0
Announcement Date 04/04/23 04/04/23
1CZK in Million2CZK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022
Net sales 1 2,380 2,447
EBITDA 1 8.327 -29.82
EBIT 1 -13.99 -47.67
Operating Margin -0.59% -1.95%
Earnings before Tax (EBT) 1 -24.68 -64.01
Net income 1 -25.5 -64.94
Net margin -1.07% -2.65%
EPS - -25.76
Free Cash Flow - -22.49
FCF margin - -0.92%
FCF Conversion (EBITDA) - -
FCF Conversion (Net income) - -
Dividend per Share - -
Announcement Date 04/04/23 04/04/23
1CZK in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022
Net Debt 1 - -
Net Cash position 1 71.6 20.7
Leverage (Debt/EBITDA) - -
Free Cash Flow - -22.5
ROE (net income / shareholders' equity) - -38.3%
ROA (Net income/ Total Assets) - -4.99%
Assets 1 - 1,302
Book Value Per Share - 55.60
Cash Flow per Share - 8.200
Capex 1 82.1 76.8
Capex / Sales 3.45% 3.14%
Announcement Date 04/04/23 04/04/23
1CZK in Million
Estimates
  1. Stock Market
  2. Equities
  3. PINK Stock
  4. Financials Pilulka Lékárny